Drospirenone - Menopausal disorders
You are here : Home > Formulary Search > Drospirenone - Menopausal disorders
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Non Formulary
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Documentation
- No records returned.
PAD Profile
ChemicalSubstance :
Drospirenone
Indication :
Menopausal disorders
Group Name :
Keywords :
Brand Names Include :
Slynd
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Other Indications
Below are listed other indications that Drospirenone is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Menopausal disorders.
- Clonidine hydrochloride
- Conjugated oestrogens
- Conjugated oestrogens with medroxyprogesterone
- Estradiol
- Estradiol with dydrogesterone
- Estradiol with levonorgestrel
- Estradiol with medroxyprogesterone
- Estradiol with norethisterone
- Estradiol with progesterone
- Ethinylestradiol
- Gabapentin
- Levonorgestrel
- Medroxyprogesterone acetate
- Paroxetine
- Pregabalin
- Progesterone
- St Johns Wort
- Tibolone
- Venlafaxine
Committee Recommendations (1)
The Surrey Heartlands Integrated Care System Area Prescribing Committee (APC) agreed a NON-FORMULARY status for
Drospirenone (Slynd®) for HRT